Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Antioxidant-balanced, diversified low-alcohol, and high-fiber low-sugar dietary patterns linked to reduced risk for OAB
Read More »Dietary Patterns Influence Development of Overactive Bladder
Likelihood of Psych Disorders Lower With Weight-Loss Surgery Versus GLP-1 RAs
Lower risks for anxiety disorders, substance use disorders, cognitive deficits seen for those undergoing metabolic and bariatric surgery
Read More »Nearly Half With Early-Stage Breast Cancer Extend Endocrine Therapy Beyond Five Years
Decision-making was influenced by patient values and did not vary by stage, race and ethnicity, or demographics
Read More »Semaglutide Offers Cardiovascular Edge Over Empagliflozin in Type 2 Diabetes
Incidence rates of composite of death, MI, stroke were lower, but not significantly so, for patients treated with semaglutide
Read More »Racial, Ethnic Differences Seen in Teens’ Use of Mental Health Services
Nearly one in three White teens report mental health visits, but this finding was significantly lower among teens from racial and ethnic minority groups
Read More »Hypertension Is Most Common Chronic Condition in People Aged 85 Years and Older
Overall, 7.4 percent of adults aged 85 years and older reported no chronic conditions, 37.3 percent reported four or more
Read More »Researchers Quantify Magnitude of Cardiovascular Risk Associated With Cannabis
Increased estimated risk ratios seen for nonfatal acute coronary syndrome, stroke, cardiovascular death
Read More »Weekly LYN-005 Provides Sustained Risperidone Release in Schizophrenia
Geometric mean ratios of LYN-005 versus immediate-release risperidone met predetermined criteria
Read More »Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop Heart Drug
By I. Edwards HealthDay ReporterWEDNESDAY, June 18, 2025 (HealthDay News) — Drugmaker Eli Lilly plans to buy Verve Therapeutics, a gene-editing startup, for about $1 billion upfront.The deal gives Lilly a potential new treatment for heart disease, The Wall Street Journal reported.The deal, announced June 17, includes a cash offer …
Read More »Kraft Heinz to Remove Artificial Dyes From Products by 2027
By I. Edwards HealthDay ReporterWEDNESDAY, June 18, 2025 (HealthDay News) — One of the nation’s largest food companies is planning a big change to its ingredients list.Kraft Heinz said it will stop using artificial dyes in all U.S. products by the end of 2027. The company also said it won’t …
Read More »